HIF1A and cancer: This pathway seems to be predominant in cancer subjected to hypoxia, displaying constitutive hypoxia-inducible factor 1 alpha (HIF1α) activation, or have defective mitochondria [27,28] and has been confirmed to occur also in vivo [28,29].